Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan-Reference-Cited by-同舟云学术

Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan

Published:2007-12-13 Issue:1 Volume:112 Page:175-187
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Kondo Masahide,Hoshi Shu Ling,Ishiguro Hiroshi,Yoshibayashi Hiroshi,Toi Masakazu

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-007-9842-y.pdf

Reference43 articles.

1. Kondo M, Toi M (2006) Cost-effective treatment options in first-line therapy for advanced breast cancer in Japan. Expert Rev Anticancer Ther 6(2):197–204

2. Miya T (2007) Current status and problems of tailor-made medicine in anticancer therapy. Gan To Kagaku Ryoho 34(4):515–519

3. Goldhirsch A, Wood WC, Gelber RD et al (2003) Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21(17):3357–3365

4. Senn HJ, Thürlimann B, Goldhirsch A et al (2003) Comments on the St. Gallen consensus 2003 on the primary therapy of early breast cancer. Breast 12(6):569–582

5. Goldhirsch A, Glick JH, Gelber RD et al (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16(10):1569–1583

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiogenomics: a key component of precision cancer medicine;British Journal of Cancer;2023-07-06

2. Biomarker and multigene assay testing in ER positive, HER-2 negative breast carcinomas: An international guidelines-based approach;Human Pathology Reports;2021-11

3. Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review;PharmacoEconomics;2019-05-13

4. Clinical analysis of 21‑gene recurrence score test in hormone receptor‑positive early‑stage breast cancer;Oncology Letters;2019-04-18

5. Ökonomische Betrachtung von Genexpressionstests beim Mammakarzinom am Beispiel des Oncotype DX®;Gesundheitsökonomie & Qualitätsmanagement;2018-07-09